Advocate Group LLC Pfizer Inc Transaction History

Advocate Group LLC

$551 Million
Q3 2024

A detailed history of Advocate Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Advocate Group LLC holds 328,830 shares of PFE stock, worth $9.03 Million. This represents 1.73% of its overall portfolio holdings.

Number of Shares

328,830

Previous 316,841 3.78%

Holding current value

$9.03 Million

Previous $8.87 Million 7.34%

% of portfolio

1.73%

Previous 1.79%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	BUY	$27.7 - $31.39 $332,095 - $376,334	11,989 Added 3.78%	328,830 $9.52 Million
Q2 2024 Jul 10, 2024	BUY	$25.26 - $29.6 $549,960 - $644,451	21,772 Added 7.38%	316,841 $8.87 Million
Q1 2024 Apr 25, 2024	BUY	$25.89 - $29.73 $1.54 Million - $1.77 Million	59,561 Added 25.29%	295,069 $8.19 Million
Q4 2023 Jan 19, 2024	BUY	$26.13 - $33.94 $275,619 - $357,999	10,548 Added 4.69%	235,508 $6.78 Million
Q3 2023 Oct 17, 2023	BUY	$32.09 - $37.51 $174,344 - $203,791	5,433 Added 2.47%	224,960 $7.46 Million
Q2 2023 Jul 20, 2023	BUY	$36.12 - $41.79 $444,817 - $514,643	12,315 Added 5.94%	219,527 $8.05 Million
Q1 2023 Apr 19, 2023	BUY	$39.39 - $51.28 $362,939 - $472,493	9,214 Added 4.65%	207,212 $8.45 Million
Q4 2022 Jan 18, 2023	BUY	$41.75 - $54.5 $198,563 - $259,202	4,756 Added 2.46%	197,998 $0
Q3 2022 Oct 19, 2022	BUY	$43.76 - $53.42 $87,826 - $107,213	2,007 Added 1.05%	193,242 $8.46 Million
Q2 2022 Jul 27, 2022	BUY	$46.53 - $55.17 $8.9 Million - $10.6 Million	191,235 New	191,235 $10 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advocate Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advocate Group LLC with notifications on news.

Account

Advocate Group LLC Pfizer Inc Transaction History